Pilot study of a European oncology regimen reference library and matching algorithm
Mirjam Crul1, Robert Terkola2, Christophe Bardin3
1Clinical Pharmacology and Pharmacy, VUMC, Amsterdam, The Netherlands m.crul@vumc.nl.
A new algorithm successfully matches European oncology regimens, enabling standardized cancer treatment data comparison across Europe. This validates a master library for reliable real-world usage analysis.
Area of Science:
- Oncology
- Health Informatics
- Data Standardization
Background:
- Lack of a European data standard for oncology regimens hinders real-world treatment data comparison.
- The Oncology Data Network developed a unified reference database, the Core Regimen Reference Library (CRRL).
- An automated matching algorithm was designed to standardize regimen data.
Purpose of the Study:
- To pilot test an automated algorithm for matching oncology regimens against a standardized European database.
- To assess the feasibility of computerised matching compared to manual expert review.
Main Methods:
- A diverse sample of 47 European oncology regimens were codified to the common data standard.
- An automated matching algorithm was applied to match regimens to the CRRL.
- An expert pharmacist panel from the European Society of Oncology Pharmacy (ESOP) performed a single-blind test on 12 selected regimens.
Main Results:
- The expert pharmacist panel validated the algorithm's feasibility.
- Full concurrence was achieved between manual and computerised matching of regimens.
- The algorithm's rules and logic were validated for comparing regimen characteristics.
Conclusions:
- The validation of the matching algorithm and the master library approach by ESOP instills confidence.
- The developed system is suitable for reliable comparison of real-world oncology regimen usage across Europe.
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis
Targeted Cancer Therapies
There are several types of targeted therapies against...
